Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Invest New Drugs. 2013 Oct 10;31(6):1539–1546. doi: 10.1007/s10637-013-0029-6

Table 1.

Patient Characteristics

Characteristic No. %
No. of patients 23
Median age, year 61
 Range 22–74
Sex
 Male 14 61
 Female 9 39
Performance status
 0 3 13
 1 18 78
 2 2 9
Primary tumor type
 Colorectal 6 26
 Sarcoma 4 17
 Pancreas 2 9
 Non-small cell lung 2 9
 Head and neck 2 9
 Other** 7 30
Prior systemic* therapy
 0 0 0
 1 4 17
 2 2 9
 3 6 26
 4 3 13
 5 2 9
 ≥6 6 26
*

Includes conventional chemotherapy, cytokine-based immunotherapy, and experimental cytotoxic chemotherapy.

**

One each of bladder, gastric, GIST, ovarian, germ cell, mesothelioma and lymphoma.